Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Revenue by Segment

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Net Product	7.28B	7.63B	7.48B	7.32B	7.17B	7.08B	6.93B	6.94B
Net Product Growth	1.57%	7.79%	7.98%	5.43%	3.59%	2.67%	-24.47%	-28.06%
Collaboration	6.32B	6.06B	5.82B	5.60B	5.39B	5.50B	5.72B	5.33B
Collaboration Growth	17.26%	10.08%	1.76%	4.99%	6.56%	11.99%	35.65%	25.76%
Other	480.00M	515.00M	548.10M	572.20M	537.00M	536.10M	451.30M	397.20M
Other Growth	-10.61%	-3.94%	21.45%	44.06%	38.72%	46.84%	39.46%	17.38%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.